On 6 May 2024, 20 days after chemotherapy, the tumour markers were as follows: CEA: 10.40 ng/mL, NSE: 35.10 ng/mL, CYFRA21-1: 2.98 ng/mL, SCC: 1.50 ng/mL. This evidence concerns the gene CEACAM5 and neoplasm.